Skip to main content

Table 1 General and clinical characteristics of patients with acute pulmonary embolism (APE)

From: Importance of oxidative stress in the evaluation of acute pulmonary embolism severity

 

Controls

(n:21)

Low-risk

(n:14)

Intermediate-risk

(n:16)

High-risk

(n:17)

p

Gender (M/F)

11/10

7/7

4/12

11/6

BMI (mm2/kg)

25.34 ± 2.51

27.83 ± 5.54

29.99 ± 4.11

27.87 ± 4.95

> 0.05

Hypertension (n)

5

8

7

 

Diabetes mellitus (n)

2

3

1

 

COPD (n)

3

1

5

 

Immobilization (n)

10

10

12

 

Trauma (n)

0

2

0

 

Malignancy (n)

4

5

6

 

Pregnancy (n)

1

1

1

 

Major general surgery (n)

3

5

5

 

Pulse rate per minute

94.79 ± 10.8

87.88 ± 14.19

98.71 ± 19.41

< 0.05

Number of breaths per minute

22.21 ± 5.12

23.75 ± 4.91

25.18 ± 5.26

< 0.05

Systolic blood pressure (mmHg)

120 ± 8.15

119.29 ± 11.91

120.31 ± 14.66

92.65 ± 13.71

< 0.05

Diastolic blood pressure (mmHg)

82.34 ± 3.64

72.86 ± 8.25

75.31 ± 9.57

59.71 ± 11.79

< 0.01

 C-reactive protein (mg/dL)

1.87 ± 0.09

44.64 ± 39.16

54.62 ± 43.93

55.04 ± 44.73

< 0.01

Leukocyte counts ( /mm³)

7896 ± 1498

8945 ± 3812

9281 ± 3466

9730 ± 4815

< 0.05

Hemoglobin (g/dL)

12.46 ± 1.74

12.44 ± 1.5

10.89 ± 3.3

11.81 ± 2.76

> 0.05

Hematocrit (%)

41.85 ± 3.76

35.73 ± 4.22

34.24 ± 5.53

35.98 ± 8.27

> 0.05

Platelet counts ( /mm³)

325.87 ± 48.98

273.79 ± 93.67

288.5 ± 164.3

199.29 ± 91.27

< 0.01

Albumin (g/dL)

4.12 ± 0.34

3.59 ± 0.29

3.52 ± 0.45

3.01 ± 0.91

> 0.05

Total protein (g/dL)

7.83 ± 0.2

6.76 ± 0.35

6.67 ± 0.4

6.36 ± 0.33

> 0.05

NT-proBNP (pg/mL)

35.72 ± 24.65

75.21 ± 67.2

274.32 ± 490.56

809.76 ± 705.12

< 0.001

cTnT (ng/mL)

0 ± 0.01

0 ± 0.01

0.03 ± 0.09

0.04 ± 0.09

> 0.05

  1. COPD, chronic obstructive pulmonary disease; NT-proBNP, N-terminal prohormone of brain natriuretic peptide